β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (vol 393, pg 1597, 2019)

被引：0
|
作者：
Villanueva, C.
Albillos, A.
Genesca, J.
机构：
来源：
LANCET | 2019年 / 393卷 / 10190期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2492 / 2492
页数：1
相关论文
共 50 条
  • [21] Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial
    Kirschner, Janbernd
    Schessl, Joachim
    Schara, Ulrike
    Reitter, Bernd
    Stettner, Georg M.
    Hobbiebrunken, Elke
    Wilichowski, Ekkehard
    Bernert, Guenther
    Weiss, Simone
    Stehling, Florian
    Wiegand, Gert
    Mueller-Felber, Wolfgang
    Thiele, Simone
    Grieben, Ulrike
    von der Hagen, Maja
    Luetschg, Juerg
    Schmoor, Claudia
    Ihorst, Gabriele
    Korinthenberg, Rudolf
    LANCET NEUROLOGY, 2010, 9 (11): : 1053 - 1059
  • [22] Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK
    Denison, Fiona C.
    Carruthers, Kathryn F.
    Hudson, Jemma
    McPherson, Gladys
    Chua, Gin Nie
    Peace, Mathilde
    Brewin, Jane
    Hallowell, Nina
    Scotland, Graham
    Lawton, Julia
    Norrie, John
    Norman, Jane E.
    PLOS MEDICINE, 2019, 16 (12)
  • [23] Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial
    Engstrom, Mats
    Berg, Thomas
    Stjernquist-Desatnik, Anna
    Axelsson, Sara
    Pitkaranta, Anne
    Hultcrantz, Malou
    Kanerva, Mervi
    Hanner, Per
    Jonsson, Lars
    LANCET NEUROLOGY, 2008, 7 (11): : 993 - 1000
  • [24] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dogar, Omara
    Keding, Ada
    Gabe, Rhian
    Marshall, Anna-Marie
    Huque, Rumana
    Barua, Deepa
    Fatima, Razia
    Khan, Amina
    Zahid, Raana
    Mansoor, Sonia
    Kotz, Daniel
    Boeckmann, Melanie
    Elsey, Helen
    Kralikova, Eva
    Parrott, Steve
    Li, Jinshuo
    Readshaw, Anne
    Sheikh, Aziz
    Siddiqi, Kamran
    LANCET GLOBAL HEALTH, 2020, 8 (11): : E1408 - E1417
  • [25] Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
    Rangaka, Molebogeng X.
    Wilkinson, Robert J.
    Boulle, Andrew
    Glynn, Judith R.
    Fielding, Katherine
    van Cutsem, Gilles
    Wilkinson, Katalin A.
    Goliath, Rene
    Mathee, Shaheed
    Goemaere, Eric
    Maartens, Gary
    LANCET, 2014, 384 (9944): : 682 - 690
  • [26] Effect of Punica granatum Extract Supplementation in Patients With Liver Cirrhosis: A Randomised, Double-Blind, Placebo-Controlled Trial☆
    Namdar, A. B.
    Ghafouridehgolan, F.
    Rakhshandeh, H.
    Sanaei, H.
    Jarrahi, L.
    Mohammadmousaei, F.
    Rajabian, A.
    JOURNAL OF HERBAL MEDICINE, 2023, 42
  • [27] Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial (vol 12, pg 339, 2013)
    Allen, C.
    LANCET NEUROLOGY, 2013, 12 (09): : 846 - 846
  • [28] Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial
    Richette, Pascal
    Latourte, Augustin
    Sellam, Jeremie
    Wendling, Daniel
    Piperno, Muriel
    Goupille, Philippe
    Pers, Yves-Marie
    Eymard, Florent
    Ottaviani, Sebastien
    Ornetti, Paul
    Flipo, Rene-Marc
    Fautrel, Bruno
    Peyr, Olivier
    Bertola, Jean Pierre
    Vicaut, Eric
    Chevalier, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 349 - 355
  • [29] Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
    Wang, Yeming
    Zhang, Dingyu
    Du, Guanhua
    Du, Ronghui
    Zhao, Jianping
    Jin, Yang
    Fu, Shouzhi
    Gao, Ling
    Cheng, Zhenshun
    Lu, Qiaofa
    Hu, Yi
    Luo, Guangwei
    Wang, Ke
    Lu, Yang
    Li, Huadong
    Wang, Shuzhen
    Ruan, Shunan
    Yang, Chengqing
    Mei, Chunlin
    Wang, Yi
    Ding, Dan
    Wu, Feng
    Tang, Xin
    Ye, Xianzhi
    Ye, Yingchun
    Liu, Bing
    Yang, Jie
    Yin, Wen
    Wang, Aili
    Fan, Guohui
    Zhou, Fei
    Liu, Zhibo
    Gu, Xiaoying
    Xu, Jiuyang
    Shang, Lianhan
    Zhang, Yi
    Cao, Lianjun
    Guo, Tingting
    Wan, Yan
    Qin, Hong
    Jiang, Yushen
    Jaki, Thomas
    Hayden, Frederick G.
    Horby, Peter W.
    Cao, Bin
    Wang, Chen
    LANCET, 2020, 395 (10236): : 1569 - 1578
  • [30] Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
    Machado, Pedro M.
    McDermott, Michael P.
    Blaettler, Thomas
    Sundgreen, Claus
    Amato, Anthony A.
    Ciafaloni, Emma
    Freimer, Miriam
    Gibson, Summer B.
    Jones, Sarah M.
    Levine, Todd D.
    Lloyd, Thomas E.
    Mozaffar, Tahseen
    Shaibani, Aziz, I
    Wicklund, Matthew
    Rosholm, Anders
    Carstensen, Tim Dehli
    Bonefeld, Karen
    Jorgensen, Anders Norkaer
    Phonekeo, Karina
    Heim, Andrew J.
    Herbelin, Laura
    Barohn, Richard J.
    Hanna, Michael G.
    Dimachkie, Mazen M.
    LANCET NEUROLOGY, 2023, 22 (10): : 900 - 911
12345